All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

/images/Cortellis_Flagship_Logo_TM_RGB_Color.png
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • Diagnosing and tracking COVID-19
    • Drugs to Watch 2020
    • The next pandemic
    • Premium reports
      • BioWorld Financings Reports
      • Disease Forecast Reports

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, March 3, 2021
Home » Authors » Ned Stafford

Ned Stafford

Articles

ARTICLES

Germany's Rhön-Klinikum, Swiss firm Medgate to form telemedicine firm

Jan. 14, 2019
By Ned Stafford
No Comments

Israeli data security firm Cynerio raises $7M, will help drive US growth

Jan. 11, 2019
By Ned Stafford
No Comments

Facial analysis study led by FDNA shows AI can detect genetic disorders

Jan. 10, 2019
By Ned Stafford
No Comments

Pq Bypass nabs $60M to develop its Detour system

Jan. 9, 2019
By Ned Stafford
No Comments
HAMBURG, Germany – Startup company Pq Bypass Inc. has completed a round of funding that can provide up to an aggregate of $60 million in equity financing to be used to advance clinical develop of its Detour system, which treats long blockages in leg arteries caused by peripheral arterial disease. The goal of the company is to eventually win U.S. FDA clearance for the system.
Read More

JC Medical reports first successful US treatment of its J-Valve TF system

Jan. 8, 2019
By Ned Stafford
No Comments

Sophia Genetics raises $77M to help fund U.S. expansion, acquire talent

Jan. 7, 2019
By Ned Stafford
No Comments

Curium and Progenics to collaborate in Europe on imaging agent PyL

Jan. 7, 2019
By Ned Stafford
No Comments
HAMBURG, Germany – Paris-based company Curium has signed an exclusive agreement with U.S. firm Progenics Pharmaceuticals Inc. to develop and commercialize in Europe a small-molecule positron emission topography (PET) imaging agent designed by Progenics to visualize prostate cancer.
Read More

Curium and Progenics to collaborate in Europe on imaging agent PyL

Jan. 4, 2019
By Ned Stafford
No Comments

Brainscope gets FDA nod to add indications for TBI device

Jan. 3, 2019
By Ned Stafford
No Comments

Edwards wins FDA approval for Sapien 3 Ultra

Dec. 31, 2018
By Ned Stafford
No Comments
HAMBURG, Germany – Edwards Lifesciences Corp. received U.S. FDA approval to market its Sapien 3 Ultra system for transcatheter aortic valve replacement in severe, symptomatic aortic stenosis patients who are at intermediate or greater risk of open-heart surgery.
Read More
View All Articles by Ned Stafford

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 2.
  • Gloved hand places sample tubes in PCR system

    COVID-19 test makers are adapting for variants

    BioWorld MedTech
    As COVID-19 variants have emerged, so have questions about the effectiveness of tests for infection. While the risk of mutations significantly limiting their...
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech's briefs for March 2.
  • Celltrion-Regkirona-2-9

    Celltrion wins first conditional Korean approval for COVID-19 antibody Regkirona

    BioWorld
    HONG KONG – Celltrion Inc. has received conditional marketing authorization from the Ministry of Food and Drug Safety (MFDS) for its anti-COVID-19 monoclonal...
cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • About
    • Archives
    • Today's news
    • Search BioWorld Science
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
A Clarivate Analytic solution. Link to Clarivate website.
Follow Us

Copyright ©2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing